Skip to main content
Erschienen in: Critical Care 3/2014

Open Access 01.06.2014 | Erratum

Erratum to: The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials

verfasst von: Qi-Hong Chen, Yi Yang, Hong-Li He, Jian-Feng Xie, Shi-Xia Cai, Ai-Ran Liu, Hua-Ling Wang, Hai-Bo Qiu

Erschienen in: Critical Care | Ausgabe 3/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​cc13926) contains supplementary material, which is available to authorized users.
The online version of the original article can be found at 10.​1186/​cc13185

Competing interests

The authors declare that they have no competing interests.
After publication of our article in a recent issue of Critical Care[1], inconsistencies were identified in Figure 6. Four trials - by Fuentes-Orozco and colleagues [2, 3], Hall and colleagues [4], and Goeters and colleagues [5] - were allocated to the wrong subgroup in our meta-analysis. They should have been included in the first subgroup (glutamine <0.3 g/kg per day); this does not change the significance of the results (P = 0.01). The correct Figure 6 is given here in full as Figure 1.

Competing interests

The authors declare that they have no competing interests.
download
DOWNLOAD
print
DRUCKEN
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Chen QH, Yang Y, He HL, Xie JF, Cai SX, Liu AR, Wang HL, Qiu HB: The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Crit Care. 2014, 18: R8-10.1186/cc13185.PubMedPubMedCentralCrossRef Chen QH, Yang Y, He HL, Xie JF, Cai SX, Liu AR, Wang HL, Qiu HB: The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Crit Care. 2014, 18: R8-10.1186/cc13185.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A, Arenas-Márquez H, Cabrera-Pivaral C, Cervantes-Guevara G, Barrera-Zepeda LM: L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004, 23: 13-21. 10.1016/S0261-5614(03)00055-4.PubMedCrossRef Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A, Arenas-Márquez H, Cabrera-Pivaral C, Cervantes-Guevara G, Barrera-Zepeda LM: L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004, 23: 13-21. 10.1016/S0261-5614(03)00055-4.PubMedCrossRef
3.
Zurück zum Zitat Fuentes-Orozco C, Cervantes-Guevara G, Muciño-Hernández I, López-Ortega A, Ambriz-González G, Gutiérrez-de-la-Rosa JL, Gómez-Herrera E, Hermosillo-Sandoval JM, González-Ojeda A: L-alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr. 2008, 32: 403-411. 10.1177/0148607108319797.PubMedCrossRef Fuentes-Orozco C, Cervantes-Guevara G, Muciño-Hernández I, López-Ortega A, Ambriz-González G, Gutiérrez-de-la-Rosa JL, Gómez-Herrera E, Hermosillo-Sandoval JM, González-Ojeda A: L-alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr. 2008, 32: 403-411. 10.1177/0148607108319797.PubMedCrossRef
4.
Zurück zum Zitat Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R: A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med. 2003, 29: 1710-1716. 10.1007/s00134-003-1937-2.PubMedCrossRef Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R: A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med. 2003, 29: 1710-1716. 10.1007/s00134-003-1937-2.PubMedCrossRef
5.
Zurück zum Zitat Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone HG: Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002, 30: 2032-2037. 10.1097/00003246-200209000-00013.PubMedCrossRef Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone HG: Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002, 30: 2032-2037. 10.1097/00003246-200209000-00013.PubMedCrossRef
Metadaten
Titel
Erratum to: The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials
verfasst von
Qi-Hong Chen
Yi Yang
Hong-Li He
Jian-Feng Xie
Shi-Xia Cai
Ai-Ran Liu
Hua-Ling Wang
Hai-Bo Qiu
Publikationsdatum
01.06.2014
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 3/2014
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13926

Weitere Artikel der Ausgabe 3/2014

Critical Care 3/2014 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.